adenosine diphosphate has been researched along with Glioblastoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Alvez, FL; Bona, NP; da Silva Dos Santos, F; de Farias, AS; de Moraes Meine, B; Luduvico, KP; Pedra, NS; Soares, MSP; Spanevello, RM; Spohr, L; Stefanello, FM | 1 |
Bogo, MR; Cappellari, AR; de Fraga Dias, A; Diz, FM; Figueiró, F; Filippi-Chiela, EC; Grave, N; Kist, LW; Leal, GF; Lenz, G; Morrone, FB; Rockenbach, L; Scheffel, TB; Thomé, MP; Vargas, P | 1 |
Campanella, R; Caroli, M; Carrabba, G; Cordiglieri, C; Costa, A; Gaudino, C; Guarnaccia, L; La Verde, N; Locatelli, M; Luzzi, S; Mantovani, G; Marfia, G; Navone, SE; Rampini, P; Riboni, L; Trombetta, E | 1 |
Du, F; Jiang, W; Ren, Y; Sun, Y; Wang, Z | 1 |
Andriantsitohaina, R; Bakalara, N; Bousseau, S; Clarion, L; Germain, S; Gueguen, N; Hilairet, G; Khiati, S; Le Mao, M; Lenaers, G; Marchand, M; Martinez, MC; Recoquillon, S; Soleti, R; Vergori, L | 1 |
5 other study(ies) available for adenosine diphosphate and Glioblastoma
Article | Year |
---|---|
Tannic Acid Attenuates Peripheral and Brain Changes in a Preclinical Rat Model of Glioblastoma by Modulating Oxidative Stress and Purinergic Signaling.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antioxidants; Brain; Glioblastoma; Nitrites; Oxidative Stress; Rats; Reactive Oxygen Species; Superoxide Dismutase; Tannins; Thiobarbituric Acid Reactive Substances | 2022 |
P2Y
Topics: Adenosine Diphosphate; Autophagy; Blood Platelets; Cell Proliferation; Glioblastoma; Humans; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor | 2022 |
Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.
Topics: Adenosine Diphosphate; Adult; Aged; Biomarkers, Tumor; Blood Platelets; Brain Neoplasms; Cells, Cultured; Endothelial Cells; Female; Glioblastoma; Humans; Male; Middle Aged; Neovascularization, Pathologic; Peptide Fragments; Phosphotransferases (Alcohol Group Acceptor); Platelet Membrane Glycoproteins; Prognosis; Sphingosine-1-Phosphate Receptors; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Tumor treating fields combined with a poly (adenosine diphosphate-ribose) polymerase inhibitor during radiotherapy for rapidly progressing IDH-wildtype diffuse astrocytoma: a case report.
Topics: Adenosine Diphosphate; Astrocytoma; Brain Neoplasms; Female; Glioblastoma; Humans; Middle Aged; Ribose | 2021 |
Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Extracellular Matrix; Galectin 1; Glioblastoma; Glycosylation; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Phosphines; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Zebrafish | 2019 |